share_log

Aadi Bioscience Q1 2024 GAAP EPS $(0.68) Misses $(0.65) Estimate, Sales $5.353M Miss $6.454M Estimate

Benzinga ·  May 8 08:02

Aadi Bioscience (NASDAQ:AADI) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.65) by 4.62 percent. The company reported quarterly sales of $5.353 million which missed the analyst consensus estimate of $6.454 million by 17.06 percent. This is a 8.76 percent decrease over sales of $5.867 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment